La cadena de opciones muestra datos clave de las opciones de acciones de Lovesac a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Lovesac..

Lovesac (NASDAQ:LOVE) Bolsa, Cadena de Opciones

Lovesac

The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.

The Lovesac Co

LOVE GROUP GLOBAL LTD by LOVE GROUP GLOBAL LTD.

LOVE HEMP GROUP PLC by LOVE HEMP GROUP PLC

Love Hemp Group PLC

The Company expects full year 2025 free cash flow conversion of 90% or greater on adjusted net income.

News

Guidance

HUBB

Hubbell Expects FY25 Adj. EPS Of $17.35 - $17.85 (Est $17.70); Anticipates Total Sales Growth And Organic Sales Growth Of 4% - 5%

Lancaster Colony (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LANC#NASDAQ">LANC</a>) reported quarterly earnings of $1.78 per share which missed the analyst consensus estimate of $1.93 by 7.77 percent. This is a 7.77 percent decrease over earnings of $1.93 per share from the same period last year. The company reported quarterly sales of $509.30 million which beat the analyst consensus estimate of $495.47 million by 2.79 percent. This is a 4.81 percent increase over sales of $485.92 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

LANC

Lancaster Colony Q2 EPS $1.78 Misses $1.93 Estimate, Sales $509.30M Beat $495.47M Estimate

Rosenblatt analyst Steve Frankel maintains Harmonic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) with a Buy and maintains $16 price target.

Price Target

Analyst Ratings

HLIT

Rosenblatt Maintains Buy on Harmonic, Maintains $16 Price Target

Biotech

General

PYXS

Pyxis Oncology Initiates Phase 1/2 Combination Trial Of PYX-201 With KEYTRUDA

Northland Capital Markets analyst Mike Grondahl maintains Applied Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) with a Outperform and raises the price target from $12 to $20.

APLD

Northland Capital Markets Maintains Outperform on Applied Digital, Raises Price Target to $20

Shares of Applied Materials Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) have risen by 9.11% this year despite last week&#8217;s declines in semiconductor-linked companies fueled by the emergence of <a href="https://www.benzinga.com/25/01/43379565/deepseeks-ai-model-shook-wall-street-but-a-new-report-says-chinese-state-accounts-helped-fan-the-flames">DeepSeek&#8217;s V3</a> chatbot. Here&#8217;s what the company&#8217;s technical and fundamental metrics reveal.
What Happened: Applied Materials is a U.S. company that provides equipment, services, and software for manufacturing semiconductors, displays, and solar products to chipmakers.
While most semiconductor-linked and chipmaker stocks took a hit after DeepSeek&#8217;s chatbot emerged as the top application on the Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) app store, AMAT has risen by 2.86% over the last five trading sessions.
However, the technical analysis of its simple daily moving averages signals a short-term downtrend with a potential for a slight rebound.
AMAT shares closed Friday at $178.80, significantly lower than its 200-day simple moving average of $197.50, and 20-day average at $180.68. Also, lower than its eight-day average of $178.64, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. However, the stock was above its 50-day average of $174.63, which acted as support, and indicated some signs of stabilization.
The momentum indicators for the stock were mixed. The relative strength index of 50.47 shows that the stock is in the neutral zone. whereas the positive MACD (moving average convergence/divergence) indicator of 1.46 suggests potential for upward momentum in the near term.
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/04070742/AMAT-tech-Chart-1024x576.png" alt="" class="wp-image-764620" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/04070742/AMAT-tech-Chart-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/04070742/AMAT-tech-Chart-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/04070742/AMAT-tech-Chart-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/04070742/AMAT-tech-Chart-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/04070742/AMAT-tech-Chart.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
See Also: <a href="https://www.benzinga.com/general/market-summary/25/02/43454291/winner-winner-chicken-dinner-tyson-foods-q1-beat-showcases-improved-execution-in-poultry-says-ceo" target="_blank" rel="noreferrer noopener">Winner Winner, Chicken Dinner: Tyson Foods Q1 Beat Showcases ‘Improved Execution&#8217; In Poultry, Says CEO</a>
Why It Matters: The company will report its first-quarter earnings on Feb. 13 after market close. Applied Materials has continuously exceeded its earnings <a href="https://www.benzinga.com/quote/AMAT/earnings">expectations</a> over the last 10 quarters, as tracked by Benzinga. 
Benzinga&#8217;s consensus expects it to deliver earnings of $2.32 per share on the revenue of $7.19 billion in the first quarter.
Despite a mixed technical picture for the stock, the 27 analysts <a href="https://www.benzinga.com/quote/AMAT/analyst-ratings">tracked by Benzinga</a> remain positive on the company with a &#8216;buy&#8217; rating and consensus price target of $207.7.
The targets range between $140 to $280, with the three recent issuances by Susquehanna, Keybanc, and Barclays indicating an average of $196.67 apiece, which implies a 9.86% upside.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/AMAT/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="378" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/04070647/AMAT-ANR-1024x378.png" alt="" class="wp-image-764619" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/04070647/AMAT-ANR-1024x378.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/04070647/AMAT-ANR-300x111.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/04070647/AMAT-ANR-768x284.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/04070647/AMAT-ANR.png 1066w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Price Action: Applied Materials was up 0.22% in premarket on Tuesday, whereas the exchange-traded fund tracking Nasdaq 100, Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) was up 0.13% at $518.76. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/etfs/sector-etfs/25/02/43456454/bill-gates-says-nvidias-jensen-huang-could-be-wrong-about-quantum-computing-qubt-rgti-ionq-react-in-tuesday-premarket">Bill Gates Says Nvidia&#8217;s Jensen Huang &#8216;Could Be Wrong&#8217; About Quantum Computing: QUBT, RGTI, IONQ React In Tuesday Premarket</a></li>
</ul>
Photo courtesy: Shutterstock

Equities

Technicals

Markets

Trading Ideas

AAPL

AMAT

Chip Equipment Maker Applied Materials Stock Is Up Over 9% YTD Even As Charts Point To Bearish Patterns: Here's What Investors Should Look At

ADM Expects FY25 Adjusted EPS Of $4.00 - $4.75 (Est $4.67), Reflecting Weaker Market Fundamentals And On-going Biofuel And Trade Policy Uncertainty

IPXX 

USA Rare Earth And Inflection Point Report Additional $15.25M Of PIPE Funding

Madison Square Garden (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSGS#NYSE">MSGS</a>) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.26 by 80.77 percent. This is a 91.53 percent decrease over earnings of $0.59 per share from the same period last year. The company reported quarterly sales of $357.759 million which beat the analyst consensus estimate of $352.678 million by 1.44 percent. This is a 9.44 percent increase over sales of $326.898 million the same period last year.

MSGS

Madison Square Garden Q2 2025 GAAP EPS $0.05 Misses $0.26 Estimate, Sales $357.759M Beat $352.678M Estimate

Cummins Sees FY25 Revenue Down 2% To Up 3%, EBITDA Margin 16.2% To 17.2% Of Sales

These proactive actions will further reduce the Company's costs in response to ongoing market challenges, including global legislative and regulatory policy uncertainty. Specifically, ADM expects to achieve the majority of the cost savings on an annual run-rate basis through improvement in manufacturing costs, reduction in purchased materials and services, and targeted workforce reduction.&nbsp;

ADM Reveals Targeted Actions To Deliver $500M - $750M In Cost Savings Over Next 3 - 5 Years; Currently Expects Targeted Workforce Reduction Of 600 - 700 Roles Globally In 2025

Rosenblatt analyst Blair Abernethy maintains PTC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTC#NASDAQ">PTC</a>) with a Buy and maintains $204 price target.

Rosenblatt Maintains Buy on PTC, Maintains $204 Price Target

The dividend is payable on March 11, 2025 to shareholders of record on February 18, 2025. This is ADM's 93rd consecutive year of uninterrupted dividends.

Dividends

ADM Boosts Cash Dividend From $0.50 To $0.51 Per Share

Health Care

CPIX

Cumberland Pharmaceuticals Announces Advance Results From The Phase 2 FIGHT DMD Trial In Duchenne Muscular Dystrophy Heart Disease

Cummins Q4 2024 GAAP EPS $3.02, Sales $8.447B Beat $8.071B Estimate

Northland Capital Markets analyst Michael Latimore maintains Palantir Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) with a Market Perform and raises the price target from $38 to $80.

PLTR

Northland Capital Markets Maintains Market Perform on Palantir Technologies, Raises Price Target to $80

Rosenblatt analyst Hans Mosesmann maintains Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) with a Buy and maintains $250 price target.

Rosenblatt Maintains Buy on Advanced Micro Devices, Maintains $250 Price Target

Hubbell (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBB#NYSE">HUBB</a>) reported quarterly earnings of $4.10 per share which beat the analyst consensus estimate of $4.02 by 1.99 percent. This is a 11.11 percent increase over earnings of $3.69 per share from the same period last year. The company reported quarterly sales of $1.33 billion which missed the analyst consensus estimate of $1.41 billion by 5.48 percent. This is a 0.89 percent decrease over sales of $1.35 billion the same period last year.

Hubbell Q4 2024 Adj EPS $4.10 Beats $4.02 Estimate, Sales $1.33B Miss $1.41B Estimate

ATI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) reported quarterly earnings of $0.79 per share which beat the analyst consensus estimate of $0.61 by 29.51 percent. This is a 23.44 percent increase over earnings of $0.64 per share from the same period last year. The company reported quarterly sales of $1.20 billion which beat the analyst consensus estimate of $1.09 billion by 10.02 percent. This is a 12.78 percent increase over sales of $1.06 billion the same period last year.

ATI Q4 2024 Adj EPS $0.79 Beats $0.61 Estimate, Sales $1.20B Beat $1.09B Estimate

Simplify Asset Management launched the Simplify Currency Strategy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOXY#NYSE">FOXY</a>), an <a href="https://www.benzinga.com/etfs">actively managed fund</a> designed to benefit from foreign exchange market dynamics. The launch on Tuesday comes as global currency volatility rises, driven by Trump's push to weaken the dollar and uncertainty around tariffs.
In an interview with Benzinga, Managing Director, Portfolio Manager, and Emerging Markets Specialist at Simplify, Christopher Getter said, &#8220;There really isn't anything available to investors in the space, so in some sense, our ability to be original with a distinct product that is not an expression on the dollar, per se—although there are a handful of single currency products out there—motivated us.&#8221;
Also Read: <a href="https://www.benzinga.com/25/02/43438809/teucrium-expands-etf-offerings-with-yields-for-you-strategy-a-etf">Teucrium Expands ETF Offerings with Yields For You Strategy A ETF</a>
The new ETF employs two strategies to generate returns with minimal dependence on equities or bonds. The first strategy is an Emerging Markets carry trade, utilizing eight currency pairs, each benchmarked against the U.S. dollar. The fund will hold &#8220;long&#8221; positions in the four currencies offering the highest interest rates while &#8220;shorting&#8221; the four with the lowest rates. This strategy seeks to profit from yield differentials and currency fluctuations.
The second strategy takes six different pairs of G10 currencies. It involves taking &#8220;long&#8221; positions in the three currencies exhibiting the strongest yield momentum increases, while &#8220;shorting&#8221; the three with the weakest. The strategy benefits from the mean-reverting nature of G10 currencies, potentially lowering overall risk by combining lesser-correlated approaches across different markets. &#8220;This approach, which we have refined through a number of iterations, provided the best alpha and return potential,&#8221; Getter added.
The backdrop of global currency fluctuations makes FOXY's launch particularly timely. &#8220;Beyond the direct targets of tariffs like Mexico and China, we think the EM currencies can do well against the USD, which should provide a boost to performance,&#8221; said Getter.
The ETF also accounts for heightened FX volatility driven by geopolitical tensions and trade policies, such as the fresh batch of tariffs. &#8220;Without getting too deep into the specifics, we can scale our exposures at both the individual currency level as well as at the overall portfolio level to either take advantage of volatility or to adopt more of a defensive posture,&#8221; said Getter.
Amid policy uncertainty and geopolitical shifts, actively managed currency strategies like FOXY could offer investors an alternative way to diversify and hedge against volatile FX markets. &#8220;Correlations across traditional asset classes (think of a typical 60/40 mix) have risen, so we think there is a demand for uncorrelated asset classes and that this demand is becoming increasingly structural in nature,&#8221; Getter said.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43440361/exclusive-dogecoin-etf-justified-more-meme-coins-etfs-possible-bitwise-cio-says">EXCLUSIVE: Dogecoin ETF Justified, More Meme Coins ETFs Possible, Bitwise CIO Says</a></li>
</ul>
Photo: Shutterstock

New ETFs

Interview

ETFs

Simplify Exchange Traded Funds Simplify Currency Strategy ETF

FOXY

Simplify Launches FOXY ETF To Navigate FX Volatility, Tariff Uncertainty

The Lovesac Company ($LOVE) share price experienced a significant 31% drop immediately following disappointing revenue for Q3, missing consensus es...

Is Lovesac Company's (LOVE) a Buy-On-The-Dip Opportunity?

Lovesac issues guidance update ahead of investor event

An update from The Lovesac Company ( ($LOVE) ) is now available. The Lovesac Company hosted its 2024 Investor Day, presenting a strategic framework...

The Lovesac Company Unveils Ambitious Growth Strategy

The Lovesac Company ( ($LOVE) ) has provided an announcement. During its recent Investor Day, Lovesac highlighted its commitment to profitable grow...

Lovesac Unveils Growth Plan with EverCouch Launch

Top picks for 2025 in healthcare, consumer, tech, industrials, energy and more

Maxim keeps a Buy rating and $38 price target on Lovesac (LOVE) but calls the company a "unique secular growth story" after its first analyst day e...

Lovesac is a 'unique secular growth story', says Maxim

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new B...

3 Best Stocks to Buy Now, 12/20/2024, According to Top Analysts

Lovesac: Headwinds Are Unlikely To Subside

Mohawk Industries: Sitting On The Sidelines As Earnings Get Closer

In a regulatory filing, Lovesac (LOVE) director Albert Jack Krause disclosed the sale of 30,000 common shares of the company on January 17 at a pri...

Comments

Lovesac

Lovesac (LOVE) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL